Cargando…
Biological activity of a genetically modified BMP-2 variant with inhibitory activity
BACKGROUND: Alterations of the binding epitopes of bone morphogenetic protein-2 (BMP-2) lead to a modified interaction with the ectodomains of BMP receptors. In the present study the biological effect of a BMP-2 double mutant with antagonistic activity was evaluated in vivo. METHODS: Equine-derived...
Autores principales: | Klammert, Uwe, Nickel, Joachim, Würzler, Kristian, Klingelhöffer, Christoph, Sebald, Walter, Kübler, Alexander C, Reuther, Tobias |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2646720/ https://www.ncbi.nlm.nih.gov/pubmed/19187528 http://dx.doi.org/10.1186/1746-160X-5-6 |
Ejemplares similares
-
GDF-5 can act as a context-dependent BMP-2 antagonist
por: Klammert, Uwe, et al.
Publicado: (2015) -
Utilizing BMP-2 muteins for treatment of multiple myeloma
por: Seher, Axel, et al.
Publicado: (2017) -
A silent H-bond can be mutationally activated for high-affinity interaction of BMP-2 and activin type IIB receptor
por: Weber, Dionys, et al.
Publicado: (2007) -
A Selection Fit Mechanism in BMP Receptor IA as a Possible Source for BMP Ligand-Receptor Promiscuity
por: Harth, Stefan, et al.
Publicado: (2010) -
Specification of BMP Signaling
por: Nickel, Joachim, et al.
Publicado: (2019)